The End of Human Papillomavirus Vaccine Exceptionalism
Author:
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Academic Pediatrics
- Vol. 18 (2) , S17-S18
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized TrialPediatrics, 2017
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization PracticesMMWR. Morbidity and Mortality Weekly Report, 2016
- Achieving High Adolescent HPV Vaccination CoveragePediatrics, 2016
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015MMWR. Morbidity and Mortality Weekly Report, 2016
- The Early Benefits of Human Papillomavirus Vaccination on Cervical Dysplasia and Anogenital WartsPediatrics, 2015
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2015
- Parent and provider perspectives on immunization: Are providers overestimating parental concerns?Vaccine, 2014
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010The Journal of Infectious Diseases, 2013
- Public Health Policy and the AIDS EpidemicNew England Journal of Medicine, 1991